Actually thinking about it, that task is not an easy one and why it takes time.
The gut has between 300 - 1000 different species of bacteria 99% of which are from 30 - 40 species. The rest may included ones that are problematic to the immune system. The question then becomes which and what are their role and in which combinations?
If KEM Analysis could relate a specific set of bacteria common to the P2a patients and perhaps even variations in response to A2-73, that would be interesting. Maybe in fact in general to better understanding Alzheimer's causes.
However, I think the findings would have to be compared to 'normal' gut microbiome from patients without AD and be the sort of thing that could back up the Lund University findings in mice with human equivalent results.
Hence might be a longer process on the way in the background.
Market Data 
Markets 
AI
